article thumbnail

How To Network With Really Busy People

InfoChachkie

A version of this article previously appeared in The Wall Street Journal. Prior to the digital age, high-profile people deployed brute force to screen out unsolicited, inbound communications. Sam trusted his Assistant to set his calendar and screen out irrelevant encounters. Old School Charm. Sue.Who@acme.com).

article thumbnail

SharesPost CEO Takes On WSJ Article

socalTECH

SharesPost , the secondary marketplace for venture backed, privately owned shares of such companies as Twitter and Facebook, is taking on the Wall Street Journal for an article published last week. SharesPost said the article left readers "largely misinformed and our company unfairly maligned."

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Simple Tactics To Make Freemium Users Pay

InfoChachkie

A version of this article previously appeared in the Wall Street Journal. In the spirit of the “land grab” mentality of the day, we encouraged usage of our screen sharing technology with no thought applied to how we would convert such users into paying customers. Let''s face it.

article thumbnail

How Roambi Is Making Mobile Work For The Enterprise, with Quinton Alsbury

socalTECH

We realized that what Apple had done, was introduce a completely new way of interacting with computing devices, using touch, a rich, animated UI, and the size of the screen. Before, they had BlackBerries and smartphones, but you couldn't do much beyond email. We founded the company in 2008, inspired by and around the first iPhone.

Mobile 170
article thumbnail

Should You Really be a Startup Entrepreneur?

Both Sides of the Table

So readers of tech journals gain a bias of the chances of success. Just a month ago they were all email you! I was watching Meet the Press this morning and they put a big screen behind the guests with TweetDeck open and showing the constant stream of information about Egypt. I’m not trying to be negative.

article thumbnail

Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More

Xconomy

The biggest news this week was in oncology, hands down. Merck showed that its immunotherapy pembrolizumab (Keytruda) might become a common option for many patients newly diagnosed with advanced lung cancer, but the bigger picture is that the field is moving fast.

Pricing 52
article thumbnail

Should You Really be a Startup Entrepreneur?

Both Sides of the Table

So readers of tech journals gain a bias of the chances of success. Just a month ago they were all email you! I was watching Meet the Press this morning and they put a big screen behind the guests with TweetDeck open and showing the constant stream of information about Egypt. I’m not trying to be negative.